• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物与癌症幸存者:副作用管理中的问题

Opioids and cancer survivors: issues in side-effect management.

作者信息

Palos Guadalupe R

机构信息

Division of Internal Medicine, Department of Symptom Research, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.

出版信息

Oncol Nurs Forum. 2008 Nov;35 Suppl:13-9. doi: 10.1188/08.ONF.S1.13-19.

DOI:10.1188/08.ONF.S1.13-19
PMID:18980935
Abstract

PURPOSE/OBJECTIVES: To describe the most common side effects associated with the use of opioid treatment in patients with moderate to severe cancer pain; to discuss research findings specific to the use of opioids for cancer pain in long-term cancer survivors.

DATA SOURCES

Published research, articles from a literature review, and U. S. statistics.

DATA SYNTHESIS

Side effects associated with opioid use are a major contributor to patient reluctance to follow treatment plans for cancer pain. Clinicians must follow the critical steps necessary to build comprehensive treatment plans that include a preventive approach to side effects and opioid rotation when side effects do not resolve.

CONCLUSIONS

Side effects associated with long-term use of opioids by cancer survivors are a major contributor to patient reluctance to follow a cancer pain treatment plan. Patient education efforts must promote open and clear communication between survivors and their providers about side effects and other important issues related to long-term use of opioids in managing pain related to cancer and its treatment.

IMPLICATIONS FOR NURSING

Oncology nurses recognize that patients often require the long-term use of opioids when they experience chronic pain as a result of their disease or its treatment. The long-term physical and cognitive effects of such opioid use are not well known, despite the advances that have been made in cancer pain control and research. Survivors should communicate their concerns about side effects to the treatment team. In addition, patients and family members must be encouraged to inform their providers about personal attitudes, beliefs, and practices that may affect decisions about taking their analgesics as prescribed. Most importantly, oncology nurses must teach patients and their families to self-advocate for optimal pain relief with minimal side effects.

摘要

目的/目标:描述中重度癌症疼痛患者使用阿片类药物治疗时最常见的副作用;讨论长期癌症幸存者使用阿片类药物治疗癌症疼痛的具体研究结果。

数据来源

已发表的研究、文献综述文章及美国统计数据。

数据综合

与使用阿片类药物相关的副作用是患者不愿遵循癌症疼痛治疗方案的主要原因。临床医生必须遵循必要的关键步骤来制定全面的治疗方案,该方案包括对副作用采取预防措施,以及在副作用无法缓解时进行阿片类药物轮换。

结论

癌症幸存者长期使用阿片类药物产生的副作用是患者不愿遵循癌症疼痛治疗方案的主要原因。患者教育工作必须促进幸存者与其医疗服务提供者之间就副作用以及与长期使用阿片类药物治疗癌症及其相关疼痛的其他重要问题进行开放和清晰的沟通。

对护理的启示

肿瘤护理人员认识到,当患者因疾病或其治疗而经历慢性疼痛时,通常需要长期使用阿片类药物。尽管在癌症疼痛控制和研究方面取得了进展,但这种阿片类药物使用的长期身体和认知影响尚不清楚。幸存者应向治疗团队表达他们对副作用的担忧。此外,必须鼓励患者及其家属告知医疗服务提供者可能影响按处方服用镇痛药决策的个人态度、信仰和习惯。最重要的是,肿瘤护理人员必须教导患者及其家属自我主张,以实现副作用最小化的最佳疼痛缓解。

相似文献

1
Opioids and cancer survivors: issues in side-effect management.阿片类药物与癌症幸存者:副作用管理中的问题
Oncol Nurs Forum. 2008 Nov;35 Suppl:13-9. doi: 10.1188/08.ONF.S1.13-19.
2
The use of risk-management approaches to protect patients with cancer-related pain and their healthcare providers.运用风险管理方法保护癌症相关疼痛患者及其医疗服务提供者。
Oncol Nurs Forum. 2008 Nov;35 Suppl:20-4. doi: 10.1188/08.ONF.S1.20-24.
3
Implementing therapy with opioids in patients with cancer.对癌症患者实施阿片类药物治疗。
Oncol Nurs Forum. 2008 Nov;35 Suppl:7-12. doi: 10.1188/08.ONF.S1.7-12.
4
Cancer survivorship: history, quality-of-life issues, and the evolving multidisciplinary approach to implementation of cancer survivorship care plans.癌症幸存者护理:历史、生活质量问题以及实施癌症幸存者护理计划的多学科方法的演变
Oncol Nurs Forum. 2009 Jul;36(4):429-36. doi: 10.1188/09.ONF.429-436.
5
Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?阿片类药物相关副作用对中重度慢性非癌痛治疗不足影响的评估:曲马多,解决问题的一步?
Curr Med Res Opin. 2010 Jul;26(7):1677-84. doi: 10.1185/03007995.2010.483941.
6
Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.阿片类药物用于慢性非癌性疼痛的管理:美国介入性疼痛医师协会(ASIPP)指南更新
Pain Physician. 2008 Mar;11(2 Suppl):S5-S62.
7
Clinical approaches to special issues related to opioid therapy.阿片类药物治疗相关特殊问题的临床处理方法。
Semin Oncol Nurs. 2009 May;25(2 Suppl 1):S20-8. doi: 10.1016/j.soncn.2009.03.011.
8
Continuing education: a comprehensive approach to improving cancer pain management and patient satisfaction.
Oncol Nurs Forum. 2003 Sep-Oct;30(5):857-64. doi: 10.1188/03.ONF.857-864.
9
Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.长期低剂量或中等剂量阿片类药物治疗联合苯二氮䓬类药物和/或抗抑郁药物治疗慢性非癌性疼痛时副作用的发生率
Pain Physician. 2009 Jan-Feb;12(1):259-67.
10
Pain and symptom control in paediatric palliative care.儿童姑息治疗中的疼痛和症状控制
Cancer Surv. 1994;21:211-31.

引用本文的文献

1
Tibetan Herbal Pain-Relieving Plaster for Chronic Musculoskeletal Pain Among Cancer Survivors: Study Protocol of a Randomized, Double-Blind, Placebo-Controlled Trial.藏药止痛贴治疗癌症幸存者慢性肌肉骨骼疼痛:一项随机、双盲、安慰剂对照试验的研究方案
Front Pharmacol. 2022 May 4;13:878371. doi: 10.3389/fphar.2022.878371. eCollection 2022.
2
A Systematic Review of CheeZheng Pain Relieving Plaster for Musculoskeletal Pain: Implications for Oncology Research and Practice.CheeZheng 止痛膏治疗肌肉骨骼疼痛的系统评价:对肿瘤学研究和实践的启示。
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420918933. doi: 10.1177/1534735420918933.
3
The effect of a coix seed oil injection on cancer pain relief.
薏苡仁油注射液对癌痛的缓解作用。
Support Care Cancer. 2019 Feb;27(2):461-465. doi: 10.1007/s00520-018-4313-z. Epub 2018 Jul 4.
4
A first-in-human, double-blind, placebo-controlled, randomized, dose escalation study of DWP05195, a novel TRPV1 antagonist, in healthy volunteers.一项在健康志愿者中开展的关于新型TRPV1拮抗剂DWP05195的首次人体双盲、安慰剂对照、随机、剂量递增研究。
Drug Des Devel Ther. 2017 Apr 24;11:1301-1313. doi: 10.2147/DDDT.S128727. eCollection 2017.
5
Effects of acupuncture for cancer pain and quality of life - a case series.针灸治疗癌痛和生活质量的效果 - 病例系列。
Chin Med. 2013 Jul 30;8(1):15. doi: 10.1186/1749-8546-8-15.
6
Predictors of the trajectories of self-reported attentional fatigue in women with breast cancer undergoing radiation therapy.接受放射治疗的乳腺癌女性自我报告的注意力疲劳轨迹的预测因素。
Oncol Nurs Forum. 2010 Jul;37(4):423-32. doi: 10.1188/10.ONF.423-432.